American Renal Associates (ARA) Tops Q1 EPS by 2c

American Renal Associates (NYSE: ARA) reported Q1 EPS of $0.11, $0.02 better than the analyst estimate of $0.09. Revenue for the quarter came in at $194.7 million versus the consensus estimate of $189 million.

For earnings history and earnings-related data on American Renal Associates (ARA) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Terra Innovatum Global N.V. (NKLR) Misses Q2 EPS by 12c
• Baidu slips as Q2 results miss estimates despite growth in AI cloud business